Mounjaro®
Starting from £179.99/mo
Start journey Learn moreFor most adults, the minimum BMI for weight loss injections in the UK is 30. If you have a weight-related health condition such as high blood pressure, type 2 diabetes or sleep apnoea, that threshold drops to a BMI of 27. These are the licensed eligibility criteria for both Mounjaro (tirzepatide) and Wegovy (semaglutide) — though BMI alone never settles the question, because a prescriber assesses your full health picture before any prescription is issued. These are prescription-only medicines, and clinical assessment is a legal requirement, not a formality.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A lot of people arrive at this question after Googling their number and landing somewhere between frustrated and confused. The short version: a BMI of 29 on its own usually falls below the licensed threshold. But 29 with a diagnosis of high blood pressure, raised cholesterol, obstructive sleep apnoea, prediabetes or certain other weight-related conditions puts you squarely inside the eligibility criteria for both licensed weight loss injections currently available in the UK.
The NHS tirzepatide page confirms the licensed indications: a BMI of 30 or above, or 27 to 29.9 alongside at least one weight-related health problem. Wegovy (semaglutide) carries the same thresholds in its UK licence. These aren't arbitrary numbers; they reflect the populations studied in the clinical trials that led to UK approval.
One practical note worth knowing: if your BMI sits right on or near the threshold and you're unsure which side of the line you fall on, the NHS BMI calculator gives a verified figure you can use. Height and weight measured on the same day, with shoes off, tends to be most consistent.
There is also an ethnic-background adjustment built into UK guidance. For adults from South Asian, Chinese, Middle Eastern, Black African or African-Caribbean backgrounds, the relevant thresholds are 2.5 kg/m² lower throughout, so 27.5 instead of 30, or 24.5 instead of 27 with a comorbidity. Our page on weight loss injections at a BMI of 27 covers this in more detail if that's where your number lands.
Meeting the BMI cut-off is the starting gate, not the finish line. Prescribers look at a broader picture, and rightly so. Some conditions mean these medicines are not suitable even at a qualifying BMI, a history of certain thyroid cancers, pancreatitis, severe gastrointestinal conditions, pregnancy, and others listed in the medicine's patient information leaflet all require careful clinical consideration.
Current medicines also matter. Mounjaro (tirzepatide) can affect the absorption of oral contraceptives, which is why women on the pill are advised to add a non-oral method for the first four weeks of treatment and for four weeks after each dose increase. If you take multiple medicines, the prescriber will want to know.
Age is another factor. These injections are licensed for adults only; they are not used in under-18s. And for anyone who is pregnant, breastfeeding or planning to conceive, they are not recommended, a clear conversation with a prescriber is the right first step in that situation.
The question our prescribers hear most often is some version of: "I meet the BMI, so why do I still need a consultation?" The answer is that a prescription for a weight loss injection is a clinical decision, not a checkbox exercise. That assessment protects you, and it's the only legal route to these medicines in the UK.
The NHS and private routes both use BMI as an entry point, but the NHS applies additional criteria that are considerably stricter. Through NICE's appraisal of tirzepatide (TA1026), NHS access currently requires a BMI of 40 or above alongside four or more specific weight-related conditions, high blood pressure, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease or type 2 diabetes. A second cohort (BMI 35–39.9 with four or more conditions) became eligible in June 2026. The rollout is phased, and even meeting the criteria doesn't guarantee timely access; waiting lists through specialist services can be long.
Private treatment follows the licensed thresholds instead: BMI 30 (or 27 with a qualifying condition), assessed by a prescriber. That gap is why many people who are clinically eligible for these medicines end up exploring regulated private services rather than waiting. If you want to understand what treatment costs through a private route, our guide to weight loss injection prices covers what a legitimate private prescription typically includes.
It's also worth knowing that once treatment starts, BMI continues to play a role. At the six-month mark, prescribers review progress: NICE guidance recommends reconsidering treatment if weight loss is under 5% on the highest tolerated dose. This isn't a cliff edge, it's a checkpoint to make sure the medicine is working for you. Our overview of weight loss injections explains how the treatment journey typically unfolds beyond the first prescription.
If you're trying to work out whether your BMI and health history put you in qualifying territory, the most reliable thing you can do is get an accurate BMI reading and note any diagnosed conditions, even ones that feel minor or well-managed. Conditions like borderline hypertension or a raised fasting glucose can be clinically relevant here.
Some people time their first consultation for the start of the month, payday tends to coincide with people finally acting on something they've been thinking about for weeks. There's no wrong time to start, but if you want to understand how a specific medicine works before booking, our guide to the M injection for weight loss is a good place to read up before your consultation. If you order before midday on a working day, same-day dispatch is possible once a prescriber has reviewed and approved your consultation.
If your BMI is below 25, these injections are not licensed for weight management and no regulated prescriber should issue one. Our page specifically on weight loss injections at a BMI of 25 explains why, and what other options exist. For anyone whose number sits comfortably in the licensed range and who wants to understand the full process, checking exact eligibility is the natural next step before a consultation. You can also browse our broader weight loss information if you're still comparing approaches.
When you're ready to take that step, speak to our prescribers, the consultation is free, and a real clinician reviews every submission the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.